OneSource Specialty Pharma Ltd 2025 Integrated Report
Company: OneSource Specialty Pharma Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Integrated Report
Pages: 348
The report presents OneSource's inaugural integrated annual report after its January 2025 listing. Consolidated FY25 revenue was ₹14,448.53 million, alongside 80% renewable-energy use and disclosure of Scope 1, Scope 2 and Scope 3 emissions. The report also details a workforce of 1,304 employees, zero fatalities, and ESG initiatives including UNGC participation and CDP scoring.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.